Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aju Mathew

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Journal of Global Oncology|September 23, 2018
Global Survey of Clinical Oncology WorkforceAju Mathew
The Lancet. Oncology|December 4, 2018
Cancer trends and burden in IndiaAju Mathew
Indian Journal of Medical Ethics|July 8, 2018
Global research partnerships in advancing public health: A case study on IndiaAju Mathew
The Breast Journal|December 27, 2019
Adjuvant bisphosphonate therapy in early-stage breast cancer-Treating the soil to kill the seedAdam Brufsky, Aju Mathew
Lancet (London, England)|July 28, 2015
Bisphosphonates, bone, and breast cancer recurrenceAdam Brufsky, Aju Mathew
Nature Reviews. Clinical Oncology|September 10, 2014
Breast cancer: Zoledronic acid--more than just a bone drugAju Mathew, Adam Brufsky
ESMO Open|April 10, 2020
Awareness of predatory publishingLloyd Panjikaran, Aju Mathew
The Lancet. Oncology|July 6, 2017
TACT2: improving treatment tolerability in early breast cancerAju Mathew, Adam Brufsky
Oncology (Williston Park, N.Y.)|January 18, 2015
Bisphosphonates in breast cancer: a triple winner?Aju Mathew, Adam Brufsky
The Lancet. Oncology|September 24, 2021
Access to and affordability of cancer medicines: time to focus on the last mileBhawna Sirohi, Aju Mathew
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Journal of Global Oncology|September 23, 2018
Global Survey of Clinical Oncology WorkforceAju Mathew
The Lancet. Oncology|December 4, 2018
Cancer trends and burden in IndiaAju Mathew
Indian Journal of Medical Ethics|July 8, 2018
Global research partnerships in advancing public health: A case study on IndiaAju Mathew
The Breast Journal|December 27, 2019
Adjuvant bisphosphonate therapy in early-stage breast cancer-Treating the soil to kill the seedAdam Brufsky, Aju Mathew
Lancet (London, England)|July 28, 2015
Bisphosphonates, bone, and breast cancer recurrenceAdam Brufsky, Aju Mathew
Nature Reviews. Clinical Oncology|September 10, 2014
Breast cancer: Zoledronic acid--more than just a bone drugAju Mathew, Adam Brufsky
ESMO Open|April 10, 2020
Awareness of predatory publishingLloyd Panjikaran, Aju Mathew
The Lancet. Oncology|July 6, 2017
TACT2: improving treatment tolerability in early breast cancerAju Mathew, Adam Brufsky
Oncology (Williston Park, N.Y.)|January 18, 2015
Bisphosphonates in breast cancer: a triple winner?Aju Mathew, Adam Brufsky
The Lancet. Oncology|September 24, 2021
Access to and affordability of cancer medicines: time to focus on the last mileBhawna Sirohi, Aju Mathew
Pageof 7